Ads
related to: survival food companies
Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 15 hours agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
Drug companies pay doctors over A$11 million a year for travel and education - EconoTimes
EconoTimes· 6 days agoDrug companies are paying Australian doctors millions of dollars a year to fly to overseas...
Bayer Fights for Survival as Roundup Lawsuits Burn Cash
Bloomberg· 7 days agoBayer AG Chief Executive Officer Bill Anderson said the wave of lawsuits over its Roundup weedkiller...
The Middle Class: A Changing Class on a Global Scale, by Javier Albarracín
Hardwood Paroxysm· 2 hours agoThe middle class is often talked about as a social and economic determinant of the well-functioning...
FDA accepts Sanofi’s Sarclisa sBLA for priority review
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe US Food and Drug Administration (FDA) has accepted for priority review Sanofi...met its primary...
Colon cancer rates are rising in young Americans, but insurance barriers are making screening harder
The Conversation via Yahoo News· 23 hours agoThis meant patients would have had to pay out of pocket to cover the anesthesia needed for...
BMS secures another EC approval for Opdivo combination
Pharmaceutical Technology via Yahoo Finance· 22 hours agoPreviously, there were no marketed therapies that improved overall survival in patients with...
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 17 hours agoThis decision comes after recent consultations with the U.S. Food and Drug Administration (FDA) and...
ASCO 2024: Rakuten’s photoimmunotherapy and Keytruda combo shows efficacy in HNSCC
Clinical Trials Arena via Yahoo Finance· 2 days agoFollowing the positive results, the company now plans to start a global Phase III clinical trial...
VBI-1901 shows promise in glioblastoma interim study By Investing.com
Investing.com· 18 hours agoVBI Vaccines Inc. (NASDAQ:VBIV), a biopharmaceutical company, revealed interim data from a Phase 2b...